Our study sheds light on the link between XBP1 hyperactivation and adipogenesis, providing potential insights for designing safe and effective anti-obesity therapeutics for preclinical investigations and clinical applications (Fig. 1). This evidence concerns the gene XBP1 and obesity due to melanocortin 4 receptor deficiency.